Table 2. Medications and angiographic profiles.
| Aspirin (100 mg/d) (n=283) | Clopidogrel (25 mg/d) (n=224) | Clopidogrel (75 mg/d) (n=248) | |
|---|---|---|---|
| ACEIs, n (%) | 75 (26.5) | 59 (26.3) | 73 (29.4) |
| ARBs, n (%) | 139 (49.1) | 108 (48.2) | 132 (53.2) |
| β-Blockers, n (%) | 231 (81.6) | 185 (82.5) | 202 (81.5) |
| Statins, n (%) | 224 (79.2) | 185 (82.6) | 204 (82.5) |
| LVEF, % | 64±12 | 65±10 | 61±10 |
| Number of treated vessels*# | 1.4±1.2 | 3.1±0.9 | 3.2±1.1 |
| Type of stents, (%) | |||
| Sirolimus-eluting stent | 89.6 | 89.2 | 90.1 |
| Paclitaxel-eluting stent | 10.4 | 10.8 | 9.9 |
| Number of stents, n*# | 2.3±0.4 | 2.9±0.5 | 3.5±0.9 |
| Mean stent size, mm | 2.71±0.39 | 2.75±0.32 | 2.84±0.29 |
ACEIs, angiotensin-converting enzyme inhibitors; ARBs, angiotensin receptor blockers; LVEF, left ventricular ejection fraction; *, P<0.05 for aspirin group versus clopidogrel (25 mg/d) group; #, P<0.05 for aspirin group versus clopidogrel (75 mg/d) group.